Published in Acta Endocrinol (Copenh) on October 01, 1993
Mesothelioma and lung tumors attributable to asbestos among petroleum workers. Am J Ind Med (2000) 2.86
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy? Ann Oncol (2008) 2.26
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials. J Clin Oncol (2001) 2.21
Pleural mesothelioma and asbestos exposure among Italian oil refinery workers. Scand J Work Environ Health (1994) 2.06
Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials. Lancet (2015) 2.05
Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril. Eur J Clin Pharmacol (2015) 2.03
Diagnostic value of CYFRA 21-1 tumor marker and CEA in pleural effusion due to mesothelioma. Chest (2001) 1.71
Age-related increase of baseline frequencies of sister chromatid exchanges, chromosome aberrations, and micronuclei in human lymphocytes. Cancer Epidemiol Biomarkers Prev (1997) 1.66
Central nervous system involvement during infection by Phlebovirus toscana of residents in natural foci in central Italy (1977-1988). Am J Trop Med Hyg (1991) 1.62
Adjuvant chemotherapy plus tamoxifen compared with tamoxifen alone for postmenopausal breast cancer: meta-analysis of quality-adjusted survival. Lancet (1996) 1.58
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case-control study. Ann Oncol (2006) 1.52
Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet (1995) 1.49
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancer. Ann Oncol (2010) 1.47
Sulphate transporter gene mutations in apparently isolated club foot. J Med Genet (2001) 1.47
Increased insulin-like growth factor (IGF)-II and IGF/IGF-binding protein ratio in prepubertal constitutionally tall children. J Clin Endocrinol Metab (2002) 1.45
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian study. J Clin Oncol (1994) 1.44
Effects of recombinant human thyrotropin on heart rate variability and blood pressure in patients on l-thyroxine-suppressive therapy for differentiated thyroid carcinoma. Horm Res (2005) 1.42
Pre-surgical treatment with somatostatin analogues in patients with acromegaly: the case for. J Endocrinol Invest (2012) 1.40
Activity of GH/IGF-I axis in trauma and septic patients during artificial nutrition: different behavior patterns? J Endocrinol Invest (2002) 1.40
Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapy. Cancer J Sci Am (1997) 1.38
Expression of ER, PgR, HER1, HER2, and response: a study of preoperative chemotherapy. Ann Oncol (2007) 1.17
Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2009. Int Angiol (2010) 1.14
CA 19-9 and CA 50 in benign and malignant pancreatic and biliary diseases. Cancer (1988) 1.13
Minimal and small size invasive breast cancer with no axillary lymph node involvement: the need for tailored adjuvant therapies. Ann Oncol (2004) 1.10
Phase-II study of Navelbine in advanced breast cancer. Semin Oncol (1989) 1.09
In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol (1992) 1.08
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancer. Ann Oncol (2007) 1.06
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease. Ann Oncol (2006) 1.06
Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol Biomarkers Prev (1998) 1.04
Fulvestrant for advanced male breast cancer patients: a case series. Ann Oncol (2011) 1.04
[Narrative inquiries representations and self-esteem in the child affected by tumor: a pre-test pilot study]. Minerva Pediatr (2010) 1.02
Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis. J Thromb Haemost (2008) 1.02
Normal age-dependent values of serum insulin growth factor-I: results from a healthy Italian population. J Endocrinol Invest (2008) 0.99
ROC curves are a suitable and flexible tool for the analysis of gene expression profiles. Cytogenet Genome Res (2003) 0.99
Hypothalamic-pituitary-adrenal axis impairment in the pathogenesis of rheumatoid arthritis and polymyalgia rheumatica. J Endocrinol Invest (2002) 0.98
Mechanisms of light adaptation in toad rods. Exp Biol (1985) 0.98
Evidence for an increased somatomedin-C/insulin-like growth factor I content in primary human lung tumors. Cancer Res (1986) 0.96
Oxytocin response to an experimental psychosocial challenge in adults exposed to traumatic experiences during childhood or adolescence. Neuroscience (2009) 0.96
Predictors of morbidity and mortality in acromegaly: an Italian survey. Eur J Endocrinol (2012) 0.96
Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer (2009) 0.96
Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in somatostatin analogue-naive patients with acromegaly. J Endocrinol Invest (2009) 0.95
Simian virus-40 sequences are a negative prognostic cofactor in patients with malignant pleural mesothelioma. Genes Chromosomes Cancer (2000) 0.95
Hypoglycemia in a dog with a leiomyoma of the gastric wall producing an insulin-like growth factor II-like peptide. Eur J Endocrinol (1995) 0.94
Cost-of-illness study in acromegalic patients in Italy. J Endocrinol Invest (2004) 0.94
Multimodal imaging in the congenital pulmonary lymphangiectasia-congenital chylothorax-hydrops fetalis continuum. Lymphology (2004) 0.94
Lymphodynamics in the fetus and newborn. Lymphology (2006) 0.93
The insulin-like growth factor axis and plasma lipid levels in the elderly. J Clin Endocrinol Metab (1998) 0.93
Exposure to negative emotional cues and alcohol cue reactivity with alcoholics: a preliminary investigation. Behav Res Ther (1997) 0.93
Opinions concerning euthanasia, life-sustaining treatment and acceleration of death: results of an Italian Association of Medical Oncology (AIOM) survey. Ann Oncol (2008) 0.92
Spironolactone and hydrochlorothiazide exert antioxidant effects and reduce vascular matrix metalloproteinase-2 activity and expression in a model of renovascular hypertension. Br J Pharmacol (2010) 0.92
Effect of epidermal growth factor on insulin-like growth factor-I (IGF-I) and IGF-binding protein synthesis by adult rat hepatocytes. Mol Cell Endocrinol (1992) 0.92
Lymphatic microsurgery for the treatment of lymphedema. Microsurgery (2006) 0.91
Insulin-like growth factor-I and angiographically documented coronary artery disease. Am J Cardiol (1996) 0.91
Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Atherosclerosis (2001) 0.90
The neurochemical maturation of the rabbit cerebellum. J Anat (1995) 0.90
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole. Breast Cancer Res Treat (2012) 0.90
Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology (1981) 0.89
Determination of progabide and its main acid metabolite in biological fluids using high-performance liquid chromatography and electrochemical detection. Application to the measurement of blood/plasma partition ratio. J Chromatogr (1984) 0.89
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest. J Clin Oncol (1996) 0.89
Role of blood groups as prognostic factors in primary breast cancer. Oncology (1990) 0.89
Combined treatment with chemotherapy and radiotherapy in high-risk FIGO stage III-IV endometrial cancer patients. Gynecol Oncol (2004) 0.88
Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Cell Biochem (2000) 0.88
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancer. Ann Oncol (2009) 0.88
Effect of low dose tamoxifen on the insulin-like growth factor system in healthy women. Breast Cancer Res Treat (2001) 0.88
Thyroid hormone stimulates the production of insulin-like growth factor I (IGF-I) by immature rat Sertoli cells. Mol Cell Endocrinol (1990) 0.88
Role of microRNAs in malignant mesothelioma. Cell Mol Life Sci (2014) 0.88
A phase II trial with cisplatin-paclitaxel cytotoxic treatment and concurrent external and endocavitary radiation therapy in locally advanced or recurrent cervical cancer. Oncology (2006) 0.87
The synthetic retinoid fenretinide lowers plasma insulin-like growth factor I levels in breast cancer patients. Cancer Res (1993) 0.87
Hemostatic parameters and platelet activation by flow-cytometry in normal pregnancy: a longitudinal study. Int J Clin Lab Res (1994) 0.87
Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. Cancer (2001) 0.86
Ozone air pollution and daily mortality in Genoa, Italy between 1993 and 1996. Public Health (2005) 0.86
Monotherapy with nilutamide, a pure nonsteroidal antiandrogen, in untreated patients with metastatic carcinoma of the prostate. The Italian Prostatic Cancer Project. J Urol (1991) 0.86
Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels. Anticancer Res (1996) 0.85
Similar embryotoxic effects of sera from infertile patients and exogenous interferon-gamma on long-term in-vitro development of mouse embryos. Hum Reprod (1999) 0.85
A case-controlled study on the quality of life in a cohort of patients with history of differentiated thyroid carcinoma. J Endocrinol Invest (2005) 0.85
Socioeconomic status and survival of gastric cancer patients. Eur J Cancer (1998) 0.85
Goserelin acetate with or without flutamide in the treatment of patients with locally advanced or metastatic prostate cancer. The Italian Prostatic Cancer Project (PONCAP) Study Group. Eur J Cancer (1993) 0.85
Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol (2013) 0.84
Risk of new primaries after chemotherapy and/or tamoxifen treatment for early breast cancer. Ann Oncol (1996) 0.84
Adjuvant immunochemotherapy in colorectal cancer Dukes C. Oncology (1987) 0.84
Growth factors in the ovary. J Endocrinol Invest (1992) 0.84
In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J Clin Endocrinol Metab (1993) 0.84
Endocrine effects of tamoxifen in postmenopausal breast cancer patients. Tumori (1984) 0.84
Somatostatin receptor distribution and function in immune system. Dig Liver Dis (2004) 0.84
Epidermal growth factor in breast cyst fluid: relationship with intracystic cation and androgen conjugate content. Cancer Res (1988) 0.84
Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia. Leukemia (1997) 0.84
Suramin and serum insulin-like growth factor levels in metastatic cancer patients. Anticancer Res (1994) 0.84
Chromosome aberrations in hospital workers: evidence from surveillance studies in Italy (1963-1993). Am J Ind Med (1997) 0.84
Congenital fetal and neonatal visceral chylous effusions: neonatal chylothorax and chylous ascites revisited. A multicenter retrospective study. Lymphology (2012) 0.83
Carboplatin in advanced hormone refractory prostatic cancer patients. Eur J Cancer (1993) 0.83
Treatment of advanced pancreatic carcinoma with the somatostatin analogue BIM 23014. Preliminary results of a pilot study. Cancer (1992) 0.83
Absence of histological malignancy in a patient cohort with follicular lesions on fine-needle aspiration. J Endocrinol Invest (2003) 0.83
Phase IIa study of fenretinide in superficial bladder cancer, using DNA flow cytometry as an intermediate end point. J Natl Cancer Inst (1994) 0.83